World's Best Scientists 2026 revealed!
Gilles Pialoux

Gilles Pialoux

D-Index & Metrics

Microbiology

D-Index
72
Citations
27648
World Ranking
1709
National Ranking
102

Overview

Gilles Pialoux is affiliated with Tenon Hospital in France and has contributed extensively to the field of medicine, with a particular focus on infectious diseases. Their scholarly output comprises 175 publications, with significant work in subfields such as infectious diseases, epidemiology, virology, hepatology, and emergency medicine.

The scientist has contributed to research on topics including:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • SARS-CoV-2 and COVID-19 Research
  • HIV, Drug Use, Sexual Risk
  • Hepatitis C virus research

Gilles Pialoux has collaborated frequently with several researchers, with the most common coauthors being:

  • Karine Lacombe
  • Jean-Michel Molina
  • J. Chas
  • Laurence Meyer
  • Philippe Sogni

The scientist's works have appeared mainly in the following publication venues:

  • Médecine et Maladies Infectieuses Formation
  • Journal of Antimicrobial Chemotherapy
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Infectious Diseases Now

Notable recent papers include:

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial, 2021, The Lancet Respiratory Medicine
  • Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection, 2020, New England Journal of Medicine
  • Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study, 2022, The Lancet HIV
  • Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study, 2020, The Lancet HIV
  • High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Pre-exposure Prophylaxis Trial, 2020, Clinical Infectious Diseases

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

    Abstr Act;C. Capitant;B. Spire;G. Pialoux

  • Chikungunya, an epidemic arbovirosis.

    Gilles Pialoux;Bernard-Alex Gaüzère;Stéphane Jauréguiberry;Michel Strobel

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

  • Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

    Adriano Lazzarin;Thomas Campbell;Bonaventura Clotet;Margaret Johnson

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy

    D Descamps;P Flandre;V Calvez;G Peytavin

  • Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

    Jean-Michel Molina;Jean-Michel Molina;Isabelle Charreau;Bruno Spire;Laurent Cotte

  • Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.

    Ana Canestri;Franæois-Xavier Lescure;Stephane Jaureguiberry;Antoine Moulignier

  • Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

    Caroline Besson;Aicha Goubar;Jean Gabarre;Willy Rozenbaum

  • Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation

    A Brisson-Noel;C Aznar;C Chureau;S Nguyen

  • Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.

    Jean-Michel Molina;Isabelle Charreau;Christian Chidiac;Gilles Pialoux

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

    Antonella Castagna;Franco Maggiolo;Giovanni Penco;David Wright

  • Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

    Eric Rosenthal;Marilyne Poirée;Christian Pradier;Christian Perronne

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

    Florence Ader;Maude Bouscambert-Duchamp;Maya Hites;Nathan Peiffer-Smadja;Nathan Peiffer-Smadja

  • A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients

    Gilles Pialoux;François Raffi;Françoise Brun-Vezinet;Vincent Meiffrédy

  • High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO Trial.

    Y. Yazdanpanah;C. Fagard;D. Descamps;A. M. Taburet

  • High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics

    Etienne Ruppé;Etienne Ruppé;Laurence Armand-Lefèvre;Laurence Armand-Lefèvre;Candice Estellat;Candice Estellat;Paul-Henri Consigny

  • Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

Frequent Co-Authors

Jean-Michel Molina
Jean-Michel Molina Université Paris Cité
Stanislas Pol
Stanislas Pol Université Paris Cité
Bertrand Dupont
Bertrand Dupont Necker-Enfants Malades Hospital
Laurence Meyer
Laurence Meyer University of Paris-Saclay
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University
Cécile Goujard
Cécile Goujard University of Paris-Saclay
Patrice Cacoub
Patrice Cacoub Sorbonne University
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open diverse career opportunities for microbiology students. For those interested in public health, several easy admission online MPH programs offer flexible paths with less stringent entry barriers. These programs equip graduates with crucial skills to tackle community health issues through a microbiological lens.

Alternatively, careers in healthcare support, such as becoming a certified child life specialist salary roles, provide meaningful work helping children cope with medical challenges. Understanding microbiology can enhance your ability to contribute in clinical and therapeutic settings.

For individuals with unique backgrounds, discovering the best degree for felons is vital for re-entry into the workforce. Many online programs accommodate diverse student profiles, including those rebuilding their careers, offering pathways into science and healthcare industries.

Those interested in holistic health might consider becoming a functional medicine NP. This career combines microbiology knowledge with alternative medical approaches, focusing on patient-centered wellness and chronic disease management.

Best Scientists Citing Gilles Pialoux

Trending Scientists